| Quarterly Financials | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 75 | 109 | 102 | 118 | 108 | 112 | 117 | 119 | 125 | 123 | 135 | 122 | 143 | 147 | 156 | 165 | 176 | 179 | 192 | 199 | 208 | 215 | 226 | 238 | 243 |
| Expenses | 70 | 116 | 89 | 100 | 96 | 99 | 102 | 105 | 108 | 106 | 117 | 106 | 124 | 128 | 134 | 142 | 149 | 154 | 164 | 170 | 177 | 184 | 194 | 209 | 213 |
| EBITDA | 5 | -7 | 13 | 18 | 12 | 13 | 14 | 15 | 17 | 17 | 19 | 16 | 19 | 20 | 22 | 24 | 26 | 25 | 28 | 29 | 31 | 32 | 32 | 29 | 30 |
| Operating Profit % | 6 % | -13 % | 12 % | 15 % | 10 % | 11 % | 11 % | 11 % | 11 % | 12 % | 12 % | 12 % | 12 % | 12 % | 12 % | 13 % | 13 % | 12 % | 12 % | 13 % | 13 % | 13 % | 13 % | 10 % | 11 % |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 4 | 6 | 7 | 7 | 8 | 7 | 8 | 8 | 8 |
| Interest | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 2 |
| Profit Before Tax | 2 | -11 | 9 | 15 | 8 | 10 | 11 | 12 | 14 | 14 | 16 | 13 | 15 | 16 | 18 | 20 | 23 | 18 | 20 | 20 | 21 | 23 | 24 | 20 | 20 |
| Tax | 1 | 2 | -0 | 2 | 2 | 3 | 3 | 3 | -1 | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 6 | 5 | 5 | 5 | 5 | 6 | 6 | 5 | 4 |
| Net Profit | 1 | -12 | 9 | 12 | 6 | 7 | 8 | 8 | 15 | 10 | 12 | 9 | 11 | 12 | 14 | 15 | 17 | 14 | 16 | 16 | 16 | 18 | 18 | 15 | 16 |
| EPS in ₹ | 0.36 | -6.47 | 5.18 | 6.75 | 3.24 | 3.67 | 4.11 | 3.81 | 6.97 | 4.50 | 5.59 | 4.23 | 5.37 | 5.79 | 6.75 | 7.26 | 8.17 | 6.47 | 7.49 | 7.45 | 7.77 | 8.43 | 8.48 | 7.12 | 7.58 |
Windlas Biotech
Windlas Biotech
812.30
-0.80
(-0.10%)
Market Cap
1,714.50 Cr
PE Ratio
25.19
Volume
46,954.00
Day High - Low
828.95 - 797.15
52W High-Low
1,097.90 - 697.40
Key Fundamentals
Market Cap
1,714.50 Cr
EPS
31.60
PE Ratio
25.19
PB Ratio
2.88
Book Value
281.35
EBITDA
104.74
Dividend Yield
0.79 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
12.06
Debt to Equity
0.04
Actual
Company News
View All News
Windlas Biotech uploads Q4FY26 call recording
May 22, 2026
May 22, 2026Windlas Biotech has uploaded the audio recording of its Q4FY26 conference call. The recording covers audited consolidated and standalone results for FY26.
Windlas Biotech grants 37,000 stock optionsMay 21, 2026
May 21, 2026Windlas Biotech granted 37,000 stock options under ESOS 2023 and Windlas Plan 2025. Options vest over 1-4 years.
Windlas Biotech disclosed a temporary operations disruption on May 18, 2026, due to statewide labour unrest in Uttarakhand. Production was restored by the evening shift across all sites.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,789.90 | #1 4,29,457.00 | 37.31 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 44.62 | |
6,533.00 | 1,73,430.60 | 67.49 | 10,560.00 | 8.73 | 2,520 | 13.44 | 44.07 | |
4,317.90 | 1,46,137.40 | 68.30 | 13,753.00 | 19.18 | 2,028 | -26.91 | 46.97 | |
1,379.30 | 1,11,417.20 | 28.84 | 27,711.70 | -2.46 | 3,783 | -55.32 | 53.76 | |
1,078.30 | 1,08,502.20 | 21.16 | 26,719.70 | 13.65 | 5,242 | 7.82 | 69.53 | |
1,274.00 | 1,06,333.50 | 25.59 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.69 | |
2,249.80 | 1,02,825.60 | #1 19.21 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 42.84 | |
2,299.00 | 94,903.90 | 48.97 | 14,277.60 | 12.03 | 1,750 | 31.75 | 42.75 | |
1,429.20 | 83,008.20 | 23.70 | 33,384.70 | 3.21 | 3,376 | 1.99 | 46.16 | |
1,382.60 | 74,640.60 | 83.88 | 6,812.90 | #1 21.03 | 884 | 21.18 | 74.67 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
16.22 %
Net Income Growth
8.62 %
Cash Flow Change
-37.42 %
ROE
-6.73 %
ROCE
-4.30 %
EBITDA Margin (Avg.)
-21.17 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 290 | 298 | 339 | 296 | 491 | 529 | 626 | 761 | 907 |
| Fixed Assets | 87 | 64 | 70 | 96 | 91 | 109 | 179 | 223 | 273 |
| Current Assets | 144 | 121 | 168 | 194 | 382 | 354 | 431 | 525 | 627 |
| Capital Work in Progress | 53 | 5 | 0 | 0 | 8 | 15 | 6 | 5 | 56 |
| Investments | 23 | 122 | 116 | 23 | 65 | 107 | 173 | 223 | 62 |
| Other Assets | 128 | 107 | 152 | 177 | 327 | 298 | 268 | 308 | 0 |
| Total Equity & Liabilities | 290 | 298 | 339 | 296 | 491 | 529 | 626 | 761 | 907 |
| Current Liabilities | 143 | 96 | 125 | 93 | 94 | 121 | 172 | 249 | 321 |
| Non Current Liabilities | 22 | 8 | 4 | 4 | 2 | 6 | 5 | 5 | 6 |
| Total Equity | 125 | 194 | 210 | 199 | 395 | 402 | 450 | 506 | 581 |
| Reserve & Surplus | 117 | 187 | 203 | 193 | 384 | 392 | 440 | 495 | 570 |
| Share Capital | 6 | 6 | 6 | 6 | 11 | 11 | 10 | 11 | 11 |
Cash Flow
| Cash Flow | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -2 | 6 | 5 | -8 | -15 | 3 | 2 | -5 |
| Investing Activities | -11 | -7 | -14 | -20 | -155 | -14 | -92 | -74 |
| Operating Activities | 35 | 19 | 25 | 12 | 9 | 61 | 109 | 68 |
| Financing Activities | -26 | -6 | -5 | 1 | 130 | -44 | -15 | 1 |
Share Holding
| % Holding | May 2021 | Aug 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Feb 2023 | Mar 2023 | Apr 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 |
| Promoter | 78.00 % | 59.95 % | 59.95 % | 59.95 % | 59.95 % | 59.95 % | 59.95 % | 60.75 % | 61.22 % | 62.44 % | 62.44 % | 62.82 % | 62.82 % | 62.82 % | 62.82 % | 62.51 % | 62.51 % | 62.51 % | 62.34 % | 62.34 % | 61.99 % | 61.99 % | 61.90 % | 63.31 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 1.35 % | 1.18 % | 1.59 % | 2.00 % | 1.55 % | 1.52 % | 1.44 % | 1.11 % | 0.93 % | 0.60 % | 0.99 % |
| DIIs | 0.00 % | 9.81 % | 9.43 % | 10.02 % | 9.62 % | 12.02 % | 11.14 % | 12.21 % | 12.27 % | 11.64 % | 11.64 % | 11.53 % | 10.47 % | 11.71 % | 11.82 % | 10.35 % | 9.58 % | 10.26 % | 10.89 % | 11.21 % | 11.43 % | 11.44 % | 11.81 % | 10.20 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 17.11 % | 20.52 % | 22.20 % | 23.61 % | 21.57 % | 22.98 % | 22.70 % | 22.18 % | 22.00 % | 22.00 % | 22.02 % | 21.63 % | 21.21 % | 21.19 % | 21.76 % | 21.80 % | 21.54 % | 21.36 % | 20.87 % | 21.30 % | 21.29 % | 21.24 % | 21.10 % |
| Others | 22.00 % | 13.13 % | 10.10 % | 7.83 % | 6.82 % | 6.47 % | 5.92 % | 4.34 % | 4.33 % | 3.92 % | 3.92 % | 3.63 % | 5.07 % | 2.90 % | 3.00 % | 3.79 % | 4.11 % | 4.14 % | 3.89 % | 4.14 % | 4.17 % | 4.35 % | 4.45 % | 4.40 % |
| No of Share Holders | 8 | 1,04,227 | 1,08,818 | 99,271 | 92,115 | 88,746 | 86,801 | 82,690 | 80,912 | 78,829 | 78,829 | 75,470 | 68,798 | 61,900 | 51,277 | 45,824 | 45,706 | 46,590 | 46,383 | 45,887 | 45,433 | 45,461 | 44,769 | 46,084 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.5 | 4 | 5.5 | 5.8 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.56 | 0.78 | 0.53 | 0.79 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 12 Sept 2022 |  Dividend | ₹ 3.50 /share | 09 Sept 2022 | 218.55 | 234.70 |
| 05 Sept 2023 | Dividend | ₹ 4.00 /share | 05 Sept 2023 | 255.00 | 389.20 |
| 17 Sept 2024 | Dividend | ₹ 5.50 /share | 17 Sept 2024 | 550.35 | 885.25 |
| 24 Sept 2024 |  Annual General Meeting | NA | 24 Sept 2024 | 819.80 | 864.90 |
| 12 Nov 2024 |  Quarterly Result Announcement | NA | 12 Nov 2024 | 1,034.75 | 1,024.40 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 976.55 | 967.65 |
| 22 May 2025 | Quarterly Result Announcement | NA | 22 May 2025 | 1,005.10 | 956.20 |
| 21 Jul 2025 | Dividend | ₹ 5.80 /share | 21 Jul 2025 | 956.20 | 923.45 |
| 28 Jul 2025 | Annual General Meeting | NA | 28 Jul 2025 | 901.65 | 984.45 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 953.65 | 937.45 |
| 06 Nov 2025 | Quarterly Result Announcement | NA | 06 Nov 2025 | 929.50 | 935.35 |
| 05 Feb 2026 | Quarterly Result Announcement | NA | 05 Feb 2026 | 771.00 | 854.55 |
| 30 Apr 2026 |  Buyback | 1000 | 24 Apr 2026 | 863.20 | 852.30 |
| 21 May 2026 | Quarterly Result Announcement | NA | 21 May 2026 | 763.55 | 798.05 |
Announcements
Announcement under Regulation 30 (LODR)-Earnings Call Transcript5 days ago
5 days agoCompliances-Reg.24(A)-Annual Secretarial Compliance7 days ago
7 days agoIntimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference CallMay 22, 2026
May 22, 2026Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Regarding Grant Of Stock Options/ Units Under WBL Employee Stock Option Scheme 2023 (ESOS 2023) And Windlas Plan 2025 (Plan)May 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 21, 2026
May 21, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 21, 2026
May 21, 2026Approval Of Audited Consolidated And Standalone Financial Results For The Year Ended March 31 2026 Along With Recommendation Of Final DividendMay 21, 2026
May 21, 2026Board Meeting Outcome for Outcome Of The Board MeetingMay 21, 2026
May 21, 2026Update Regarding Labour Protest In Dehradun
May 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 18, 2026
May 18, 2026Announcement under Regulation 30 (LODR)-Closure of Buy BackMay 18, 2026
May 18, 2026Submission Of Post Buyback Public AnnouncementMay 16, 2026
May 16, 2026Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Thursday May 21 2026May 15, 2026
May 15, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 15, 2026
May 15, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateMay 05, 2026
May 05, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Apr 30, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2026
Apr 29, 2026Submission Of Letter Of OfferApr 27, 2026
Apr 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 20, 2026
Apr 20, 2026Record DateApr 17, 2026
Apr 17, 2026Board Meeting Outcome for Regulation 30 And Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR Regulation) As Amended
Apr 17, 2026
Apr 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 15, 2026
Apr 15, 2026Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015Apr 14, 2026
Apr 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Apr 06, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 20, 2026
Mar 20, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 20, 2026
Mar 20, 2026Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 13, 2026
Mar 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2026
Feb 17, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Feb 16, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 16, 2026
Feb 16, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 11, 2026
Feb 11, 2026Sub: Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 10, 2026
Feb 10, 2026Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Recording Of Conference CallFeb 06, 2026
Feb 06, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-CessationFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 05, 2026
Feb 05, 2026Unaudited Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Feb 05, 2026Board Meeting Outcome for Approval Of Financial Results For The Quarter Ended December 31 2025Feb 05, 2026
Feb 05, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 29, 2026
Jan 29, 2026Board Meeting Intimation for Notice Of The Board Meeting Scheduled To Be Held On Thursday February 5 2026Jan 28, 2026
Jan 28, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 22, 2026
Jan 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 29, 2025
Dec 29, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 27, 2025
Nov 27, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.05% | 0 | 0.00% | 0.01% | |
Bandhan Small Cap Fund Direct-Growth | 0.08% | 0 | 0.00% | -0.01% | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct-Growth | 1.10% | 0 | 0.00% | 0.09% | |
ICICI Prudential Smallcap Fund Direct Plan-Growth | 0.19% | 0 | 0.00% | -0.04% | |
 UTI Healthcare Fund Direct-Growth | 1.23% | 0 | 0.00% | 0.08% |
Technical Indicators
RSI(14)
Neutral 51.12
ATR(14)
Volatile 33.84
STOCH(9,6)
Neutral 72.79
STOCH RSI(14)
Overbought 90.38
MACD(12,26)
Bullish 3.35
ADX(14)
Weak Trend 16.77
UO(9)
Bearish 51.09
ROC(12)
Uptrend And Accelerating 6.72
WillR(14)
Neutral -37.22
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
